Current Topics in Medicinal Chemistry
Title:Targeting Epigenetic Targets for Cancer Therapy
Volume: 18 Issue: 28
Author(s): Bin Yu
Affiliation:
Export Options
About this article
Cite this article as:
Yu Bin , Targeting Epigenetic Targets for Cancer Therapy, Current Topics in Medicinal Chemistry 2018; 18 (28) . https://dx.doi.org/10.2174/156802661828190212093039
DOI https://dx.doi.org/10.2174/156802661828190212093039 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
34
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of MicroRNA in the Diagnosis and Therapy of Hepatic Metastases from Colorectal Cancer
MicroRNA The Dark Side of Stem Cells: Triggering Cancer Progression by Cell Fusion
Current Molecular Medicine Clinical Development of Experimental Virus-Mediated Gene Therapy for Malignant Glioma
Anti-Cancer Agents in Medicinal Chemistry Alzheimers Disease and n-3 Polyunsaturated Fatty Acids: Beneficial Effects and Possible Molecular Pathways Involved
Current Signal Transduction Therapy Vitamins for Cancer Prevention and Treatment: An Insight
Current Molecular Medicine Editorial (Thematic Issue:Targeting Loss of Tumor Suppressors for Cancer Therapeutics)
Current Drug Targets Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
Current Medicinal Chemistry Editorial: Regenerative Medicine for Retinal Diseases
Current Tissue Engineering (Discontinued) Chelating Systems for 99mTc/188Re in the Development of Radiolabeled Peptide Pharmaceuticals
Anti-Cancer Agents in Medicinal Chemistry Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Editorial [Nef: A Notorious Enigmatic Factor in HIV Biology (Guest Editor: Bruno Verhasselt)]
Current HIV Research The Antibiotic Potential of Prokaryotic IMP Dehydrogenase Inhibitors
Current Medicinal Chemistry Targeting Protein Degradation in Cancer Treatment
Current Chemical Biology Inhibition of DNA Topoisomerases by a Series of Benzoxazoles and their Possible Metabolites
Letters in Drug Design & Discovery DNA-Damaging Anticancer Drugs – A Perspective for DNA Repair- Oriented Therapy
Current Medicinal Chemistry Control of Copper Status for Cancer Therapy
Current Cancer Drug Targets Patent Selections
Recent Patents on Biotechnology Patent Annotations
Recent Patents on DNA & Gene Sequences Targeting 5-Lipoxygenase Signaling Pathways to Reverse Drug Resistance in Cancer
Letters in Drug Design & Discovery Lung Cancer Stem Cells: An Epigenetic Perspective
Current Cancer Drug Targets